|
1
|
Kalinowski DS and Richardson DR: The
evolution of iron chelators for the treatment of iron overload
disease and cancer. Pharmacol Rev. 57:547–583. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mantovani A, Evans R and Alexander P:
Non-specific cytotoxicity of spleen cells in mice bearing
transplanted chemically induced fibrosarcomas. Br J Cancer.
36:35–40. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boult J, Roberts K, Brookes MJ, et al:
Overexpression of cellular iron import proteins is associated with
malignant progression of esophageal adenocarcinoma. Clin Cancer
Res. 14:379–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller LD, Coffman LG, Chou JW, et al: An
iron regulatory gene signature predicts outcome in breast cancer.
Cancer Res. 71:6728–6737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Follézou JY and Bizon M: Cancer
chemotherapy induces a transient increase of serum-iron level.
Neoplasma. 33:225–231. 1986.PubMed/NCBI
|
|
6
|
Yu Y, Gutierrez E, Kovacevic Z, et al:
Iron chelators for the treatment of cancer. Curr Med Chem.
19:2689–2702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Recalcati S, Locati M, Gammella E,
Invernizzi P and Cairo G: Iron levels in polarized macrophages:
regulation of immunity and autoimmunity. Autoimmun Rev. 11:883–889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaczmarek M, Cachau RE, Topol IA, Kasprzak
KS, Ghio A and Salnikow K: Metal ions stimulated iron oxidation in
hydroxylases facilitates stabilization of HIF-1α protein. Toxicol
Sci. 107:394–403. 2009.PubMed/NCBI
|
|
9
|
Martínez-Romero R, Martínez-Lara E,
Aguilar-Quesada R, Peralta A, Oliver FJ and Siles E: PARP-1
modulates deferoxamine-induced HIF-1α accumulation through the
regulation of nitric oxide and oxidative stress. J Cell Biochem.
104:2248–2260. 2008.PubMed/NCBI
|
|
10
|
Yang Y, Sun M, Wang L and Jiao B: HIFs,
angiogenesis, and cancer. J Cell Biochem. 114:967–974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Simiantonaki N, Taxeidis M, Jayasinghe C,
Kurzik-Dumke U and Kirkpatrick C: Hypoxia-inducible factor 1 alpha
expression increases during colorectal carcinogenesis and tumor
progression. BMC Cancer. 8:3202008. View Article : Google Scholar
|
|
12
|
Semenza GL: Hypoxia, clonal selection, and
the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol.
35:71–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vincent-Salomon A and Thiery JP: Host
microenvironment in breast cancer development:
epithelial-mesenchymal transition in breast cancer development.
Breast Cancer Res. 5:101–106. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Jiang B, Guo Z, et al:
Four-and-a-half LIM protein 2 promotes invasive potential and
epithelial-mesenchymal transition in colon cancer. Carcinogenesis.
31:1220–1229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang W, Wang J, Zou B, et al: Four and a
half LIM protein 2 (FHL2) negatively regulates the transcription of
E-cadherin through interaction with Snail1. Eur J Cancer.
47:121–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(-like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roy N, Bommi PV, Bhat UG, et al: DDB2
suppresses epithelial-to-mesenchymal transition in colon cancer.
Cancer Res. 73:3771–3782. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Higgins DF, Kimura K, Bernhardt WM, et al:
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of
epithelial-to-mesenchymal transition. J Clin Invest. 117:3810–3820.
2007.PubMed/NCBI
|
|
19
|
Jiang J, Tang YL and Liang XH: EMT: a new
vision of hypoxia promoting cancer progression. Cancer Biol Ther.
11:714–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang MH, Wu MZ, Chiou SH, et al: Direct
regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol.
10:295–305. 2008.
|
|
21
|
Zhang Q, Bai X, Chen W, et al:
Wnt/β-catenin signaling enhances hypoxia-induced
epithelial-mesenchymal transition in hepatocellular carcinoma via
crosstalk with hif-1α signaling. Carcinogenesis. 34:962–973.
2013.
|
|
22
|
Wang J, Yang Y, Xia HH, et al: Suppression
of FHL2 expression induces cell differentiation and inhibits
gastric and colon carcinogenesis. Gastroenterology. 132:1066–1076.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hollestelle A, Peeters JK, Smid M, et al:
Loss of E-cadherin is not a necessity for epithelial to mesenchymal
transition in human breast cancer. Breast Cancer Res Treat.
138:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lester BR and McCarthy JB: Tumor cell
adhesion to the extracellular matrix and signal transduction
mechanisms implicated in tumor cell motility, invasion and
metastasis. Cancer Metastasis Rev. 11:31–44. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bartolazzi A, Cerboni C, Nicotra MR,
Mottolese M, Bigotti A and Natali PG: Transformation and tumor
progression are frequently associated with expression of the alpha
3/beta 1 heterodimer in solid tumors. Int J Cancer. 58:488–491.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei L, Yang Y, Zhang X and Yu Q: Altered
regulation of Src upon cell detachment protects human lung
adenocarcinoma cells from anoikis. Oncogene. 23:9052–9061. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng Y, Ni Y, Huang X, Wang Z and Han W:
Overexpression of HIF-1α indicates a poor prognosis in tongue
carcinoma and may be associated with tumour metastasis. Oncol Lett.
5:1285–1289. 2013.
|
|
28
|
Cheli Y, Giuliano S, Fenouille N, et al:
Hypoxia and MITF control metastatic behaviour in mouse and human
melanoma cells. Oncogene. 31:2461–2470. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martinez-Outschoorn UE, Trimmer C, Lin Z,
et al: Autophagy in cancer associated fibroblasts promotes tumor
cell survival: role of hypoxia, HIF1 induction and NFκB activation
in the tumor stromal microenvironment. Cell Cycle. 9:3515–3533.
2010.PubMed/NCBI
|
|
30
|
Tanaka T and Nangaku M: Angiogenesis and
hypoxia in the kidney. Nat Rev Nephrol. 9:211–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haddad JJ, Olver RE and Land SC:
Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB
redox sensitivity. Evidence for inhibition by glutathione oxidation
in alveolar epithelial cells. J Biol Chem. 275:21130–21139.
2000.PubMed/NCBI
|
|
32
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer.
Cancer Metastasis Rev. 28:151–166. 2009.
|
